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Abstract The eukaryotic initiation factor eIF-4E from Xenopus 
laevis was expressed in Escherichia coli and refolded in an active 
form. To define the cysteine residues forming a disulfide bond in 
Xenopus eIF-4E, each of the 3 cysteine residues was changed to 
serine by site-directed mutagenesis. Cap-binding activities of the 
mutant proteins were evaluated by 7-methyl-GTP(m7GTP)-
affinity column chromatography. Even the mutant protein 
containing no cysteine showed an affinity for m7GTP. From 
the above results and the estimation of the sulfhydryl groups by 
Ellman's assay method, we concluded that a disulfide bond is not 
involved in the active Xenopus eIF-4E. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Most of the eukaryotic m R N A s have the m7G-containing 
cap structure at their 5' termini [1]. eIF-4E is the only initia-
tion factor thus far demonstrated to interact with the cap as 
an isolated polypeptide. eIF-4E also binds to eIF-4G which is 
anchored to ribosome through other initiation factors [2,3]. At 
the initiation step of translation, it is thought that the protein-
protein interaction between eIF-4E and eIF-4G brings the 
m R N A to the ribosome. 
The primary sequence of eIF-4E from a number of species 
has been determined [4—11]. However little is presently known 
about the secondary and tertiary structures of eIF-4E. One of 
the conserved structural features among the mammalian e lF-
4Es is the presence of four Cys residues. It is suggested that 
one pair of the Cys residues forms a disulfide bond [12]. Xeno-
pus eIF-4E is highly homologous to the mammalian counter-
parts whereas it has only 3 cysteine residues [10]. Recent re-
port showed that 2 of the 3 Cys residues are also conserved in 
Drosophila eIF-4E [11]. 
In this study, to determine whether a disulfide bond was 
involved in the active Xenopus eIF-4E, the mutant proteins, in 
which Cys residues were replaced by Ser residues, were ex-
pressed in E. coli, and their structure and cap-binding activity 
were studied. 
2. Materials and methods 
2.1. Materials 
The cDNA for Xenopus eIF-4E was described previously [10]. Re-
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striction enzymes, T4 DNA ligase, ficaBEST dideoxy sequencing kit 
and Takara Ex Taq were purchased from Takara Shuzo Co. Ltd. 
QIAEXII gel extraction kit was from Qiagen. 7-Methyl-GTP Sephar-
ose-4B was from Pharmacia Biotech. 7-Methyl-GTP and L-cysteine 
were obtained from Sigma Chemical Co. Centriprep-30 was purchased 
from Amicon. Protein Assay Kit was from Bio-Rad Laboratories. 
2.2. Construction of expression vector 
The plasmid containing the cDNA for Xenopus eIF-4E [10] was 
used as a template to amplify the coding region. The primers, 5'-
TTTGGTACCATGGCGGCCGTGGAACCGGA-3' (5' Ncol) and 
5'-CCTTTGGATCCTCGAGATTGCTTGACGCAGTCTCCT-3' 
(3'XB) were used for the amplification to introduce Ncol site at the 
initiation codon and BamHl site at position 50 bp downstream of the 
termination codon. The PCR reaction was performed for 8 cycles 
using 0.2 ug of the template and 100 pmol each of the primers. 
Amplified DNA was cloned into pUC19 vector and sequenced using 
BcaBEST dideoxy sequencing kit on Hitachi automated DNA se-
quencer WS-10A to confirm the integrity. The DNA was digested 
with Ncol and BamHl. The digested product was separated by elec-
trophoresis in 1% agarose gel followed by recovering with QIAEXII 
gel extraction kit (QIAGEN). The purified DNA was ligated into 
pETlld vector (Novagen) that had been linearized with Ncol and 
BamHl to make pETX4E. 
Site-directed mutagenesis was performed by the recombinant PCR 
technique using the above and following primers: 5'-TAATGTCCG-
GA TCTGACTATTCACTC-3' (C85S(+)), 5'-GAGTGAATAGT-
CAGATCCGGACATTA-3' (C85S(-)), 5'-AGACGCTCATGTCC-
CTTATTGGAGAG-3' (C132S(+)), 5'-CTCTCCAATAAGGGACA-
TGAGCGTCT-3' (C132S(-)), 5'-GCGACGATGTATCTGGCGC-
AGTTGTA-3' (C146S(+)), 5'-TACAACTGCGCCAGATACATCG-
TCGC-3' (C146S(-)). Fig. 1 shows the strategy of the recomhinant 
PCR. 
2.3. Expression, refolding and purification of elF-4E 
E. coli BL21(DE3) transformed with the eIF-4E expression vector 
pETX4E was cultured in LB medium containing 50 |ig/ml ampicillin 
at 37°C. Expression of eIF-4E was induced with 0.4 mM IPTG when 
the cells reached a density of 0.5 (Ami). The induced cells were in-
cubated for an additional 16 h and harvested by centrifugation. This 
and all subsequent procedures were carried out at 4°C or on ice. The 
cells were disrupted by sonication and centrifuged. The expressed 
protein was recovered as an inclusion body in the pellet fraction. 
The method for the refolding of denatured protein was described 
previously [13]. The pellet containing 2 mg of eIF-4E protein was 
dissolved in 10 ml of solution A (20 mM HEPES/KOH, pH 7.5, 20 
mM dithiothreitol, 1 mM EDTA, 6 M guanidine-hydrochloride) and 
incubated on ice for 2 h with occasionally shaking. The protein sol-
ution was diluted with 100 ml of solution B (20 mM HEPES/KOH, 
pH 7.5, 1 mM EDTA, 3 mM glutathione, 0.3 mM glutathione disul-
fide, 1.5 M KO Ac) and incubated at 4°C for 12 h. Then the protein 
solution was diluted with solution C (20 mM HEPES/KOH, pH 7.5, 
1 mM EDTA) to achieve a final concentration of 150 mM KOAc and 
applied to a 0.5 ml 7-methyl-GTP-Sepharose 4B column. The column 
was washed with 50 ml of solution D (20 mM HEPES/KOH, pH 7.5, 
1 mM EDTA, 100 mM KC1). The refolded eIF-4E was eluted with 0.1 
mM m7GTP in solution D and concentrated by Centriprep-30 (Ami-
con). Protein concentration was determined by the Bradford method 
using Protein Assay Kit (Bio-Rad). 
2.4. Purification of eIF-4E from Xenopus oocytes 
The excised ovary was washed with solution A (described in the 
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previous section) and homogenized with a Dounce-type homogenizer 
in the presence of equal volume of solution A containing 0.5 mM 
phenylmethylsulfonyl fluoride, 2.5 |ig/ml leupeptin, 0.1 mg/ml soybean 
trypsin inhibitor. The homogenate was centrifuged at lOOOOXg for 20 
min at 4°C. The clear middle layer was collected in a new tube and 
centrifuged again. Then the clear lysate was centrifuged at 220 000 X g 
for 2 h at 4°C. The supernatant was subjected to 7-methyl-GTP-Se-
pharose 4B column. Native Xenopus eIF-4E was eluted with m7GTP 
as described in the previous section. 
2.5. Circular dichroism measurements 
CD measurements were performed on a JASCO J-720 circular di-
chroism spectrophotometer. The light path length of the cell was 
1 mm. The cell was maintained at 20°C using a circulating water 
bath. The samples were prepared in 20 mM Tris-HCl (pH 7.5) buffer 
containing 100 mM KC1. 
2.6. Assay for free sulfliydril groups 
Sample was dissolved in solution E (0.1 M Tris-HCl (pH 8.0), 10 
mM EDTA, 6 M guanidine-hydrochloride). Free sulfhydril groups 
were assayed by Ellman's assay method [14]. 
3. Results and discussion 
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Fig. 1. Strategy of the recombinant PCR. The bold lines are the 
eIF-4E DNAs. The arrows indicate the PCR primers. Two steps of 
PCR reactions were performed. First, eIF-4E DNA was amplified 
dividing into two parts using 5' Ncol and C«S(—) primers (n indi-
cates 85, 132 or 146) for the 5' part, CnS(+) and 3' XB primers for 
the 3' part. Second, the entire region of the mutant eIF-4E DNA 
was amplified between 5' Ncol and 3' XB using the first PCR prod-
ucts as templates. The resultant fragment was cloned into pUC19 
and confirmed the sequence. 
We wished to determine whether a disulfide bond was 
present in Xenopus eIF-4E. Fig. 2 shows the alignment of 
the amino acid sequence of eIF-4Es from various species. In 
the case of mammalian eIF-4Es, 4 residues of cysteine (Cys) 
are conserved [5-7]. And it is suggested that one pair of Cys 
residues forms a disulfide bond [12]. Xenopus eIF-4E is highly 
homologous in its amino acid sequence with mammalian 
counterparts [10]. However, it has only 3 Cys residues 
(Cys85, Cysl32, Cysl46). Cysl32 and Cys 146 are also con-
served in Drosophila eIF-4E [11]. So we first assumed that 
these 2 Cys residues form a disulfide bond. 
To facilitate studies on Xenopus eIF-4E, we constructed an 
overexpression system of Xenopus eIF-4E in Escherichia coll. 
We have two different cDNAs for Xenopus eIF-4Es which 
encode products of 213 and 231 amino acids [10]. These 
clones differ by a 54-nt segment, which is present in one 
copy in the shorter clone, but in two copies in the longer 
clone. In this paper we used the shorter clone. 
The cDNA was placed into an IPTG-inducible E. coli ex-
pression vector pET-lld and the protein was expressed in E. 
coli BL21(DE3). Analysis by SDS-PAGE and staining with 
Coomassie Blue shows that the expressed eIF-4E was in the 
insoluble fraction. The expressed eIF-4E was refolded as de-
scribed in the materials and methods section and applied to 
m7GTP-affinity chromatography followed by eluting with 
m7GTP. Analysis of the amino-terminus sequence and the 
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Fig. 2. Alignment of the amino acid sequences of eIF-4Es from Xenopus [10], human [5], rabbit [7], mouse [6] and Drosophila [11]. Identical 
and absent amino acid residues are indicated with asterisks and hyphens, respectively. Cysteine residues are boxed. 
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Fig. 3. Cap-binding activities of the native eIF-4E and the recombinant proteins. Each protein was applied to m7GTP-affinity chromatography. 
Equal aliquot of the following fraction was subjected to 14% SDS-PAGE. Lanes: 1, flow through; 2, washing step; 3-10, elution with solution 
D (20 mM HEPES/KOH, pH 7.5, 1 mM EDTA, 100 mM KCl) containing 0.1 mM m7GTP. The bands in both outsides of the gel in each col-
umn are the molecular weight marker proteins. The numbers indicated at left side of the columns are the molecular weight of the marker pro-
teins. 
amino-acid composition indicated that the purified protein 
was Xenopus eIF-4E starting with Ala next to the initiation 
Met (data not shown). 
Site-directed mutagenesis was used to convert Cys85 to Ser. 
The mutant protein was expressed and refolded in the same 
manner as used in the case of wild-type eIF-4E. Cap-binding 
activity of the mutant protein was evaluated by m7GTP-affin-
ity chromatography. The mutant protein was specifically 
eluted with m7GTP from the affinity column as shown in 
Fig. 3. CD spectra of native Xenopus eIF-4E, wild-type re-
combinant eIF-4E and the mutant (C85S) protein were meas-
ured (Fig. 4). All spectra showed similar pattern characterized 
by a minimum near 207 nm and a broad shoulder beginning 
around 215 nm. At present we do not know the cause of the 
difference between the recombinant proteins and the native 
protein in the region of 230-250 nm. We focused on the re-
gion of 200-230 nm because the signals derived from typical 
secondary structures such as oc-helix and ß-sheet appear in this 
Table 1 
Estimation of the free SH groups by Ellman's assay method 
No. of Cys No. of SH group 
(mol/mol protein) 
Fig. 4. CD spectra for the native, the wild-type and the C85S mu-
tant eIF-4Es in 20 mM Tris-HCl, pH 7.5, 100 mM KCl. 
Native 3 2.9 
Wild type 3 3.1 
C85S mutant 2 2.4 
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region. In this region, the spectra resemble that of eIF-4E 
from Saccharomyces cerevisiae [15]. The difference of [9] value 
between native and the recombinant proteins would be caused 
by the error of the estimation of the amount of native eIF-4E. 
Native eIF-4E fraction contained the isoform of Xenopus e lF -
4E (Fig. 3 upper band) [10,16]. 
The contents of the sulfhydryl groups were assayed by Ell-
man ' s assay method [14] for the native, the wild-type and the 
mutan t (C85S) eIF-4Es. As shown in Table 1, the results 
suggested that all of the Cys residues were presented as sulf-
hydryls. 
Then all the Cys residues were converted to Ser residues to 
prepare a mutan t eIF-4E with no Cys residue, CallS. Actually 
this mutan t protein has a cap-binding activity as shown in 
Fig. 3. However, the recovery of the cap-binding protein 
was very low through 3 separate experiments. It is possible 
that this mutant protein is not refolded efficiently in this con-
dition. Another possibility is that these Cys residues (Cys 132, 
Cys 146) are involved in cap-binding pocket. 
Consequently, we conclude that a disulfide bond is not 
formed in Xenopus eIF-4E. The contribution of Cys residues 
to cap-binding activity should be studied in more detail. 
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